MSC therapy addresses the underlying mechanisms of chronic disease — inflammation, immune dysregulation, and tissue degradation — rather than suppressing symptoms. Below are the conditions where we have seen the strongest clinical results.
Tick-bite-induced allergy to mammalian products causing immune sensitization. MSC therapy targets the underlying immune dysregulation driving persistent reactions.
Learn about treatment →Neurodevelopmental condition with complex behavioral and communication patterns. MSC therapy targets neuroinflammation and immune dysregulation in ASD.
Learn about treatment →Prostate gland enlargement causing urinary obstruction. MSC therapy reduces prostatic inflammation and promotes tissue remodeling to improve urinary flow.
Learn about treatment →Chronic obstructive pulmonary disease causing progressive airflow limitation. MSC therapy reduces lung inflammation and supports bronchial tissue repair.
Learn about treatment →Coronary disease and heart failure driven by inflammation and myocardial injury. MSC therapy promotes cardiac regeneration and improves vascular function.
Learn about treatment →Rare persistent EBV infection causing severe immune dysregulation. MSC therapy modulates the aberrant immune response driving viral persistence and organ damage.
Learn about treatment →Progressive loss of kidney function due to inflammation, fibrosis, and nephron loss. MSC therapy reduces renal inflammation and supports tubular regeneration.
Learn about treatment →Post-Lyme syndrome with persistent fatigue, neurological symptoms, and immune dysregulation. MSC therapy targets chronic inflammation and immune rebalancing.
Learn about treatment →Intervertebral disc degeneration causing chronic back pain and radiculopathy. MSC therapy promotes disc regeneration and reduces discogenic inflammation.
Learn about treatment →Metabolic liver disease driven by fat accumulation, inflammation, and fibrosis. MSC therapy reduces hepatic inflammation and supports liver regeneration.
Learn about treatment →Androgenic and inflammatory hair follicle miniaturization causing pattern hair loss. MSC therapy stimulates follicle regeneration via growth factor signaling.
Learn about treatment →Autoimmune thyroid disease causing glandular destruction and hypothyroidism. MSC therapy modulates thyroid autoimmunity and reduces inflammatory damage.
Learn about treatment →Autoimmune thyroid overactivity causing systemic metabolic excess. MSC therapy modulates TSH-receptor autoimmunity and reduces thyroid inflammation.
Learn about treatment →Inflammatory and structural reproductive dysfunction. MSC therapy supports endometrial repair, ovarian regeneration, and immune-mediated implantation failure.
Learn about treatment →Proactive MSC protocol targeting cellular aging drivers: inflammation, senescence, and tissue deterioration — for individuals optimizing healthspan.
Learn about treatment →Autoimmune demyelinating disease of the CNS. MSC therapy targets neuroinflammation, supports remyelination, and slows progression.
Learn about treatment →Degenerative joint disease characterized by cartilage loss and chronic inflammation. MSC therapy promotes tissue regeneration and reduces pain.
Learn about treatment →Autonomic nervous system dysfunction causing debilitating orthostatic symptoms. MSC therapy targets neuroinflammation and autonomic nerve repair.
Learn about treatment →Progressive neurodegenerative disorder affecting movement and cognition. MSC therapy provides neuroprotection and modulates dopaminergic pathways.
Learn about treatment →Nerve damage causing pain, numbness, and weakness. MSC therapy supports nerve regeneration, reduces neuroinflammation, and improves sensory function.
Learn about treatment →Chronic inflammatory skin disease driven by immune dysregulation. MSC therapy suppresses keratinocyte hyperproliferation and the Th17 inflammatory cascade.
Learn about treatment →Systemic autoimmune disease causing joint inflammation and destruction. MSC therapy suppresses dysregulated immune responses and reduces articular damage.
Learn about treatment →Autoimmune exocrinopathy destroying moisture-producing glands. MSC therapy suppresses lymphocytic infiltration and restores glandular function.
Learn about treatment →Cerebrovascular event causing neurological deficit. MSC therapy reduces neuroinflammation, supports neuroregeneration, and promotes functional recovery.
Learn about treatment →Brain injury from physical trauma with lasting neurological effects. MSC therapy reduces neuroinflammation and promotes neuroplasticity.
Learn about treatment →Autoimmune destruction of pancreatic beta cells causing insulin dependence. MSC therapy modulates autoimmunity and supports residual beta-cell preservation.
Learn about treatment →Metabolic disorder of insulin resistance and beta-cell dysfunction. MSC therapy improves insulin sensitivity and reduces systemic inflammation.
Learn about treatment →Chronic inflammatory bowel disease causing colonic mucosal inflammation. MSC therapy promotes mucosal healing and restores immune tolerance in the gut.
Learn about treatment →Our team reviews every case individually. Send us your records and a coordinator will respond within 48 hours.
Request a Case Review